Wearable Devices (WLDS) COO Tamar Fleisher discloses initial share and option holdings

Rhea-AI Filing Summary

Wearable Devices Ltd. Chief Operating Officer Tamar Fleisher filed an initial ownership report showing direct holdings in the company’s ordinary shares and equity awards. The filing lists 23,667 Ordinary Shares, which include RSUs for 2,500 shares vesting in monthly installments of 417 shares through September 10, 2026 and RSUs for 16,056 shares vesting in monthly installments of 472 shares through January 1, 2029. Fleisher also holds stock options over 125 ordinary shares at an exercise price of 158.4000, expiring on December 15, 2032, and options over 63 ordinary shares at an exercise price of 316.8000, expiring on November 30, 2033. These entries reflect existing positions rather than new market purchases or sales.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fleisher Tamar

(Last) (First) (Middle)

5 HA-TNUFA STREET

(Street)

YOKNE'AM ILLIT 2066736

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Wearable Devices Ltd. [ WLDS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	23,667(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	01/01/2024	12/15/2032	Ordinary Shares	125(2)	$158.4	D
Stock option (right to buy)	08/23/2024	11/30/2033	Ordinary Shares	63(3)	$316.8	D

Explanation of Responses:

1. Includes (i) 2,500 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal monthly installments of 417 Ordinary Shares through September 10, 2026; and (ii) 16,056 Ordinary Shares issuable upon the vesting of RSUs in equal monthly installments of 472 Ordinary Shares through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.

2. The options were granted on December 15, 2022 and vest as follows: 42 options vest on the first year anniversary of the grant date and the remaining 83 options vest in equal monthly installments of 3 Ordinary Shares after the first anniversary.

3. The options were granted on August 23, 2023 and vest as follows: 21 options vest on the first year anniversary of the grant date and the remaining 42 options vest in equal monthly installments of 2 Ordinary Shares after the first anniversary.

	/s/ Tamar Fleisher	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Tamar Fleisher’s Form 3 for Wearable Devices (WLDS) report?

The Form 3 reports Tamar Fleisher’s initial ownership in Wearable Devices. It shows 23,667 Ordinary Shares held directly, plus stock options and time-based RSUs that vest in scheduled monthly installments extending into 2026 and 2029.

How many Wearable Devices (WLDS) shares does Tamar Fleisher hold directly?

Tamar Fleisher holds 23,667 Ordinary Shares directly. This amount includes shares issuable from RSUs that vest over time, combining already held stock with future shares that will be delivered as vesting milestones are reached.

What RSU vesting schedules are disclosed for WLDS COO Tamar Fleisher?

The filing discloses RSUs for 2,500 shares vesting in equal monthly installments of 417 shares through September 10, 2026, and RSUs for 16,056 shares vesting in equal monthly installments of 472 shares through January 1, 2029, each RSU delivering one Ordinary Share.

What stock options does Tamar Fleisher hold in Wearable Devices (WLDS)?

Fleisher holds options over 125 Ordinary Shares at an exercise price of 158.4000 expiring December 15, 2032, and options over 63 Ordinary Shares at an exercise price of 316.8000 expiring November 30, 2033, all reported as directly owned derivative positions.

Are there any buy or sell transactions in Tamar Fleisher’s WLDS Form 3?

No buy or sell transactions are reported. The Form 3 lists existing holdings in Ordinary Shares, RSUs, and stock options, serving as an initial snapshot of Tamar Fleisher’s equity position as an officer of Wearable Devices.

What do the option vesting terms mean in the WLDS Form 3 footnotes?

The options granted in December 2022 vest with 42 options after one year and 83 vesting monthly afterward, while those granted in August 2023 vest with 21 after one year and 42 vesting monthly, tying option availability to continued service over time.